Articles de revue sur le cancer de l'ovaire - Derni ères parutions

InTextoResearch, agence d'information scientifique


InTextoResearch vous informe sur les dernières parutions d'articles de
revue sur le cancer de l'ovaire (20 novembre 2007):

Bevacizumab in the treatment of ovarian cancer.
Han ES, Monk BJ.
Expert Rev Anticancer Ther. 2007 Oct;7(10):1339-45.

MR imaging in ovarian cancer.
Sohaib SA, Reznek RH.
Cancer Imaging. 2007 Oct 1;7 Spec No A:S119-29.

Evaluating adnexal lesions: which need follow-up?
Miller JC, Horowitz NS, Thrall JH, Lee SI.
J Am Coll Radiol. 2007 Oct;4(10):725-9.

Hereditary breast-ovarian cancer: clinical findings and medical
management.
Marshall M, Solomon S.
Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7.

Individualized preventive and therapeutic management of hereditary
breast ovarian cancer syndrome.
Roukos DH, Briasoulis E.
Nat Clin Pract Oncol. 2007 Oct;4(10):578-90.

A terrible beauty: a physician's story of ovarian cancer.
Spano LJ.
Can Fam Physician. 2007 Jun;53(6):983-5.

Profiling studies in ovarian cancer: a review.
Fehrmann RS, Li XY, van der Zee AG, de Jong S, Te Meerman GJ, de Vries
EG, Crijns AP.
Oncologist. 2007 Aug;12(8):960-6.

Role of complete lymphadenectomy in endometrioid uterine cancer.
Chan JK, Kapp DS.
Lancet Oncol. 2007 Sep;8(9):831-41.

Management of asymptomatic patients on follow-up for ovarian cancer
with rising CA-125 concentrations.
Goonewardene TI, Hall MR, Rustin GJ.
Lancet Oncol. 2007 Sep;8(9):813-21.

Genomic tests for ovarian cancer detection and management.
Myers ER, Havrilesky LJ, Kulasingam SL, Sanders GD, Cline KE, Gray RN,
Berchuck A, McCrory DC.
Evid Rep Technol Assess (Full Rep). 2006 Oct;(145):1-100.

Antiangiogenic therapy for ovarian cancer.
Rosa DD, Clamp AR, Collinson F, Jayson GC.
Curr Opin Oncol. 2007 Sep;19(5):497-505.

Pegylated liposomal doxorubicin in ovarian cancer.
Green AE, Rose PG.
Int J Nanomedicine. 2006;1(3):229-39.

Ovarian spindle cell lesions: a review with emphasis on recent
developments and differential diagnosis.
Irving JA, McCluggage WG.
Adv Anat Pathol. 2007 Sep;14(5):305-19.

Primary ovarian angiosarcoma--review of the literature and report of a
case with coexisting chylothorax.
Vavilis D, Papadopoulos N, Agorastos T, Efstratiou I, Kommoss F,
Bontis IN.
Eur J Gynaecol Oncol. 2007;28(4):287-9.

Novel agents in ovarian cancer.
Matei D.
Expert Opin Investig Drugs. 2007 Aug;16(8):1227-39.

The BRCA1/2 pathway prevents hematologic cancers in addition to breast
and ovarian cancers.
Friedenson B.
BMC Cancer. 2007 Aug 6;7:152.

The role of neoadjuvant chemotherapy versus primary surgery in the
management of stage III ovarian cancer.
Van Gorp T, Amant F, Neven P, Berteloot P, Leunen K, Vergote I.
Cancer Treat Res. 2007;134:387-402.

Cytoreduction and intraperitoneal chemotherapy for peritoneal
carcinomatosis of ovarian cancer.
Lee JM.
Cancer Treat Res. 2007;134:375-85.

Elective oophorectomy in the gynecological patient: when is it
desirable?
Parker WH, Shoupe D, Broder MS, Liu Z, Farquhar C, Berek JS.
Curr Opin Obstet Gynecol. 2007 Aug;19(4):350-4.



(contact pour InTextoResearch: Marc Lacroix, Baelen, Wallonie,
Belgique - scimedweb@mail.com)